Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1985 Apr 1;132(7):801–805.

Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium level

Pierre Larochelle, Alexander G Logan
PMCID: PMC1345870  PMID: 3884122

Abstract

In a double-blind randomized controlled trial the effects on the blood pressure and the serum potassium concentration of hydrochlorothiazide-amiloride hydrochloride (Moduret) and hydrochlorothiazide alone were compared in 266 adults who were normokalemic and had a diastolic blood pressure greater than 95 mm Hg at the time of entry into the study. The mean ages (52.2 and 53.8 years) and the proportions of men (66% and 56%) in the groups given the combination drug and hydrochlorothiazide alone respectively were similar. In the group given the combination drug the mean blood pressure, measured while the patients were supine, and the mean serum potassium level fell significantly, from 156/99 to 138/88 mm Hg and from 4.23 to 3.91 mmol/L, after 8 weeks of treatment. In the other group both measures also fell significantly, the blood pressure from 157/99 to 138/87 mm Hg and the potassium level from 4.16 to 3.69 mmol/L. The proportions of patients in the two groups with hypokalemia (14% and 29% respectively), defined as a serum potassium level below 3.5 mmol/L, differed significantly (p = 0.0026), whereas the proportions with a potassium level exceeding 4.5 mmol/L (4.5% and 3.9% respectively) were similar. Thus, the combination drug reduced the blood pressure to the same extent as hydrochlorothiazide alone but significantly less often caused hypokalemia. In light of growing concerns about the cardiovascular complications of hypokalemia, hydrochlorothiazide-amiloride appears preferable to hydrochlorothiazide alone for the treatment of some patients with hypertension.

Full text

PDF
801

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burge P. S., Montuschi E. Long-term effects of an amiloride/hydrochlorothiazide combination ('Moduretic') on electrolyte balance. Curr Med Res Opin. 1976;4(4):260–266. doi: 10.1185/03007997609109315. [DOI] [PubMed] [Google Scholar]
  2. Holland O. B., Nixon J. V., Kuhnert L. Diuretic-induced ventricular ectopic activity. Am J Med. 1981 Apr;70(4):762–768. doi: 10.1016/0002-9343(81)90530-1. [DOI] [PubMed] [Google Scholar]
  3. Koch-Weser J., O'Malley K., O'Brien E. Drug therapy: Management of hypertension in the elderly. N Engl J Med. 1980 Jun 19;302(25):1397–1401. doi: 10.1056/NEJM198006193022505. [DOI] [PubMed] [Google Scholar]
  4. Logan A. G., Milne B. J., Flanagan P. T., Haynes R. B. Clinical effectiveness and cost-effectiveness of monitoring blood pressure of hypertensive employees at work. Hypertension. 1983 Nov-Dec;5(6):828–836. doi: 10.1161/01.hyp.5.6.828. [DOI] [PubMed] [Google Scholar]
  5. Penhall R. K., Frewin D. B. Plasma potassium levels in hypertensive patients receiving fixed-combination diuretic therapy. Med J Aust. 1980 Apr 19;1(8):376–378. doi: 10.5694/j.1326-5377.1980.tb134930.x. [DOI] [PubMed] [Google Scholar]
  6. Sackett D. L., Gent M. Controversy in counting and attributing events in clinical trials. N Engl J Med. 1979 Dec 27;301(26):1410–1412. doi: 10.1056/NEJM197912273012602. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES